Bordetella pertussis

Type: Keyphrase
Name: Bordetella pertussis
First reported Sep 12 2014 - Updated Sep 12 2014 - 2 reports

Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis)

ROCKVILLE, Md."Achieving this milestone is an important step in building the foundation for our Pertussis clinical program. The next anticipated milestone for SYN-005 is to initiate cGMP manufacturing in the second half of this year, followed by the filing ... [Published Bio-Medicine - Sep 12 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

Rapid Tests, Antimicrobial Safeguards Improve Prescribing

WASHINGTON, DC — A rapid test to detect pathogens and antimicrobial resistance can lead to more judicious use of antibiotics compared to standard testing, but the key to the benefit is real-time antimicrobial checks and balances, a new study shows."An ... [Published General Medicine eJournal - Sep 12 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Meridian Bioscience and Premier sign agreement for illumigene molecular system

Meridian Bioscience Inc., a provider of clinical diagnostic test kits, has signed a new agreement with Premier, Inc. to offer the complete illumigene molecular menu of tests to its members. Premier serves more than 3,000 US hospitals and 110,000-plus ... [Published Individual.com - Sep 10 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Caspase-1-Independent Interleukin-1β Is Required for Clearance of Bordetella pertussis Infections and Whole-Cell Vaccine-Mediated Immunity

by David E. Place, Sarah J. Muse, Girish S. Kirimanjeswara, Eric T. HarvillWhooping cough remains a significant disease worldwide and its re-emergence in highly vaccinated populations has been attributed to a combination of imperfect vaccines and evolution ... [Published Plosone.org - Sep 08 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Meridian Bioscience Offers Testing Solutions to Premier

Meridian Bioscience, Inc. ( VIVO - Snapshot Report ) revealed that it has entered a new agreement with Charlotte, NC-based healthcare improvement company Premier, Inc. to offer its complete illumigene molecular testing solutions.With the agreement, ... [Published Zacks.com - Sep 04 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 3 reports

Meridian Bioscience Signs Agreement with Premier, Inc. to Offer Its Hospitals Molecular Diagnostic Tests and Instruments for C. difficile, Group B Streptococcus, Group A Streptococcus, Bordetella pertussis, and Mycoplasma pneumoniae

CINCINNATI--(EON: Enhanced Online News)--Meridian Bioscience Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has signed a new agreement with Premier, Inc. to offer the complete illumigene® molecular menu of tests to its members. Premier serves ... [Published EON Science - Sep 03 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Pertussis in a Religious Community Averse to Health Care

Notes From the FieldJames Matthias, MPH, Cristina Dusek, P. Scott Pritchard, MPH, Laura Rutledge, Paula Kinchen, Mark Lander, MSDisclosuresMorbidity and Mortality Weekly Report. 2014;63:655On August 30, 2013, the Florida Department of Health in Columbia ... [Published General Medicine eJournal - Aug 29 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

ICAAC to Showcase 'Extraordinary' Ebola Efforts

WASHINGTON, DC — The Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) is always an international affair, with about half of attendees coming from outside of the United States.This year, when delegates gather in the nation's capital ... [Published General Medicine eJournal - Aug 27 2014]
Entities: Ebola, HIV/AIDS, Pertussis
First reported Aug 22 2014 - Updated Aug 23 2014 - 1 reports

Whooping-cough alert: Get a booster before school starts

The words “whooping cough” conjure up a bygone era of gravely sick babies and desperate parents hoping their feverish, hacking children make it through the night. The devastating disease, called pertussis, is characterized by several weeks, or even months, ... [Published Consumer Reports - Aug 22 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Molecular Signatures of the Evolving Immune Response in Mice following a Bordetella pertussis Infection

by René H. M. Raeven, Jolanda Brummelman, Jeroen L. A. Pennings, Olaf E. M. Nijst, Betsy Kuipers, Laura E. R. Blok, Kina Helm, Elly van Riet, Wim Jiskoot, Cecile A. C. M. van Els, Wanda G. H. Han, Gideon F. A. Kersten, Bernard MetzWorldwide resurgence ... [Published Plosone.org - Aug 19 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Proteomics-Identified Bvg-Activated Autotransporters Protect against Bordetella pertussis in a Mouse Model

by Daan de Gouw, Marien I. de. Jonge, Peter W. M. Hermans, Hans J. C. T. Wessels, Aldert Zomer, Alinda Berends, Catherine Pratt, Guy A. Berbers, Frits R. Mooi, Dimitri A. DiavatopoulosPertussis is a highly infectious respiratory disease of humans caused ... [Published Plosone.org - Aug 18 2014]
First reported Jun 14 2014 - Updated Jun 15 2014 - 2 reports

Whooping Cough Epidemic In California

[ Life ]California’s whooping cough cases have reached epidemic level, causing concern for citizens.According to California’s public health agency, there have been 800 new cases documented in the last two weeks. As of June 10, there have been 3,458 cases ... [Published WebProNews - Jun 14 2014]

Quotes

"An antimicrobial stewardship team that reviews rapid test results and antimicrobial orders and provides feedback to providers can help clinicians understand and act upon rapid molecular test results" investigator Ritu Banerjee, MD, from the Mayo Clinic in Rochester, Minnesota, told Medscape Medical News
"Achieving this milestone is an important step in building the foundation for our Pertussis clinical program. The next anticipated milestone for SYN-005 is to initiate cGMP manufacturing in the second half of this year, followed by the filing of an IND in mid-2015 to support the initiation of a Phase I clinical trial" stated Jeffrey Riley
...an IND in mid-2015 to support the initiation of a Phase I clinical trial," stated Jeffrey Riley , Chief Executive Officer of Synthetic Biologics. "We expect this to become an important new treatment option for patients suffering from Pertussis."
Mike Shaughnessy, President of Global Diagnostics at Meridian Bioscience, commented, "This is an exciting opportunity for Meridian to coordinate with Premier to place our complete illumigene molecular menu in member facilities. Meridian is privileged to collaborate with Premier to assist its alliance members in their efforts to deliver improved clinical outcomes, improve operating efficiencies, and reduce costs in their facilities."

More Content

All (36) | News (27) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Rapid Tests, Antimicrobial Safeguards Improve P... [Published General Medicine eJournal - Sep 12 2014]
Synthetic Biologics Receives Orphan Drug Design... [Published Bio-Medicine - Sep 12 2014]
Synthetic Biologics Receives Orphan Drug Design... [Published Fat Pitch Financials - Sep 12 2014]
Meridian Bioscience and Premier sign agreement ... [Published Individual.com - Sep 10 2014]
Caspase-1-Independent Interleukin-1β Is Require... [Published Plosone.org - Sep 08 2014]
Synthetic Biologics Highlights SYN-005 Data Pre... [Published Barchart - Sep 08 2014]
Why is Whooping Cough Back? [Published PBS - Sep 05 2014]
Meridian Bioscience Offers Testing Solutions to... [Published Zacks.com - Sep 04 2014]
Meridian Bioscience Signs Agreement with Premie... [Published EON Science - Sep 03 2014]
Meridian Bioscience Signs Agreement with Premie... [Published Business Wire Science: Science News - Sep 03 2014]
Meridian Bioscience Signs Agreement with Premie... [Published Business Wire Health News - Sep 03 2014]
Pertussis in a Religious Community Averse to He... [Published General Medicine eJournal - Aug 29 2014]
ICAAC to Showcase 'Extraordinary' Ebola Efforts [Published General Medicine eJournal - Aug 27 2014]
Whooping-cough alert: Get a booster before scho... [Published Consumer Reports - Aug 22 2014]
Molecular Signatures of the Evolving Immune Res... [Published Plosone.org - Aug 19 2014]
Proteomics-Identified Bvg-Activated Autotranspo... [Published Plosone.org - Aug 18 2014]
Whooping cough outbreaks have been reported in ... [Published Ukiah Daily Journal - Aug 15 2014]
Why whooping cough vaccine needed before school... [Published Woodland Daily Democrat - Aug 08 2014]
Notes from the Field: Outbreak of Pertussis in ... [Published Full Text Reports... - Aug 03 2014]
Synthetic Biologics' collaborator to present no... [Published PharmaBiz - Jul 22 2014]
UTM™ and ESwab™ Are Ideal Collection and Transp... [Published PR Newswire: General Business - Jul 09 2014]
Whooping Cough Epidemic In California [Published WebProNews - Jun 14 2014]
Whooping Cough Epidemic In California [Published WebProNews Feed - Jun 14 2014]
Methods for the treatment or prevention of hemo... [Published PharmCast - May 21 2014]
Harriton student diagnosed with Whooping Cough [Published Main Line Times - May 19 2014]
The Whooping Cough Family [Published The Daily Scan from GenomeWeb - Apr 29 2014]
Synthetic Biologics announces positive preclini... [Published PharmaBiz - Apr 25 2014]
Whooping Cough Bacterium Evolves In Australia [Published Scientific Blogging - Apr 15 2014]
Whooping Cough Outbreak In Lethbridge, Alberta [Published WebProNews - Apr 11 2014]
Whooping Cough Outbreak In Lethbridge, Alberta [Published WebProNews Feed - Apr 11 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Meridian Bioscience Signs Agreement with Premie... [Published EON Science - Sep 03 2014]
CINCINNATI--(EON: Enhanced Online News)--Meridian Bioscience Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has signed a new agreement with Premier, Inc. to offer the complete illumigene® molecular menu of tests to its members. Premier serves ...
Meridian Bioscience Signs Agreement with Premie... [Published Business Wire Science: Science News - Sep 03 2014]
CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has signed a new agreement with Premier, Inc. to offer the complete illumigene® molecular menu of tests to its members. Premier serves more than 3,000 ...
Meridian Bioscience Signs Agreement with Premie... [Published Business Wire Health News - Sep 03 2014]
CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has signed a new agreement with Premier, Inc. to offer the complete illumigene® molecular menu of tests to its members. Premier serves more than 3,000 ...
Notes from the Field: Outbreak of Pertussis in ... [Published Full Text Reports... - Aug 03 2014]
Notes from the Field: Outbreak of Pertussis in a School and Religious Community Averse to Health Care and Vaccinations — Columbia County, Florida, 2013 Source: Morbidity and Mortality Weekly Report (CDC) On August 30, 2013, the Florida Department of Health ...
UTM™ and ESwab™ Are Ideal Collection and Transp... [Published PR Newswire: General Business - Jul 09 2014]
MURRIETA, Calif., July 9, 2014 /PRNewswire/ -- Whooping Cough is a highly contagious respiratory infection caused by bacteria named Bordetella pertussis. Whooping Cough is a vaccine preventable disease that is spreading rapidly. In fact, the US Health ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.